Search
Displaying 741–750 of 1066 results
-
Sustained Suppression of VEGF: Looking Forward and Looking Back
Research NewsThe results of the LADDER trial demonstrate a major step forward but introduce many questions.
-
Gene Therapy Trials for Wet Age-Related Macular Degeneration
Research NewsAfter a series of failed trials, current research suggests that the next generation of gene therapies for wet age-related macular degeneration holds promise. Learn how investigators are inducing the body’s cells to administer their own therapeutic response to disease activity.
-
Beacon Stories
Susan, who has retinitis pigmentosa, went through many tests in search of learning more about her eye disease. Once she enrolled in the My Retina Tracker® (MRT) testing program, Susan was provided with comprehensive results and a clear diagnosis, giving her clarity and hope.
-
The Foundation’s Contributions to Genetic Research Published in Peer-Reviewed Journal
Research NewsThe nonprofit has emerged as a driving force in genetic research and treatment development for inherited retinal diseases.
-
SparingVision Gets EU Funding Boost for Development of Cross-Cutting Gene Therapy
Research NewsA clinical trial for the treatment, designed to preserve cone photoreceptors, is planned in the US and Europe in 2020.
-
Raising Our Sights DIY Fundraising
Start your own Raising Our Sights DIY fundraising campaign today to help raise awareness for the work of Foundation Fighting Blindness and help fund our research to find meaningful treatments and cure!
-
Estate Planning 101: Establishing Your Legacy
Join our Director of Legacy Giving, John R. Corneille, J.D., and estate attorney from New York, Josh Steinberg, in our first-ever Estate Planning 101: Establishing Your Legacy session.
-
Resource
Dr. Jacque Duncan, UCSF Professor of Clinical Ophthalmology, is currently working on therapies restoring vision for retinal degenerative diseases. Dr. Duncan has hope and optimism for the future that vision will be restored for those with retinal diseases, thanks in part by the Foundation’s work.
-
The Retina is a Proving Ground for a Broad Range of Neurological Therapies
Research NewsRetinal research paves the way for new treatments for the entire neurological system.
-
Jack Sees a Different Life after LUXTURNA
Beacon StoriesJack Hogan was diagnosed with retinitis pigmentosa at only two-and-a-half years old. But with the help of connections made with the Foundation, Jack became the first-ever recipient of the FDA-approved gene therapy known as LUXTURNA.
